"Sales are up, so we're fine." I've heard that sentence in many month-end meetings. Sometimes it's true. Often it answers only 1 of 3 questions.
As a country manager you're judged on more than the sales line. Margin, cash, net price and the forecast are all yours now, and most of them are shaped by commercial decisions long before finance reports them. Step 3 of the Pharma Career Ladder for country managers is money, pricing and forecast.
Read the whole business
Sales, profit and cash ask 3 different questions. Did the customer buy? What's left after discounts, bonus goods and costs? Has the money arrived? Bonus goods cost the same to make as the units you sell, but bring in nothing. A month closed by loading the distributor raises sales, eats margin with extra bonus goods, delays payment, and starts next month in a hole. Sales is what you sold. Profit is what you kept. Cash is what arrived.
The same habit applies to reading a P&L as a commercial leader. I read 5 lines: gross sales, net sales, gross margin, commercial spend and contribution. Gross sales is what went into the trade. Net sales is the real net price you achieved, and where month-end deals quietly appear. Read net before gross, ask why each line moved, and go through it with the finance manager.
In the Gulf the health authority sets the public price. Margin gets decided in the choices you do control: discounts, rebates, bonus goods and tender bids. That's why gross margin is a strategy. Chase volume at any price and next year you have a bigger base, a thinner margin and volume you must buy all over again. Agree bonus goods in the trade terms and know the lowest acceptable net price before the tender opens.
Follow the stock and the money
Working capital in pharma is mostly created by commercial decisions. Watch 4 things: distributor inventory in months of sell-out, receivables, how fast public payers settle with the distributor, and short-dated stock anywhere in the chain. Slow money is a cost, even when the sales line looks good.
The habit underneath is reading sell-in, sell-out and inventory side by side. Sell-in is what we shipped to the distributor. Sell-out is what the distributor sold on to pharmacies and hospitals. Inventory is the stock in between. When sell-in runs ahead of sell-out, the gap sits in the warehouse and comes back later.
That's also where a forecast you can defend begins. Start from sell-out. Write each assumption down: tenders, listings, competitor moves, supply. Test it with first-line managers, who know which account is about to switch. Each month, compare what happened with each assumption. When a forecast is missed, you'll know which sentence was wrong.
Hold the net price
Price is a decision, not a reaction. A competitor discounts, a distributor wants better terms, a tender deadline is close, and each "little more" becomes the starting point for the next conversation. Decide before the pressure arrives. Agree a walk-away net price with finance for each key tender, ask what the customer actually loses if you don't match, and make approval levels clear.
When a buyer asks for better terms, bonus versus discount matters. A discount lowers the price on every unit, and once seen, it becomes everyone's starting point. Bonus goods leave the price whole and stay a term you can review. Tie bonus to sell-out, agree a written limit, and never give goods the trade can't sell before they expire. Give goods, not price.
Then keep trade terms that do not leak. Pay rebates on sell-out. Keep every term in 1 written agreement, with no side promises. Give each term a cap and an end date, reconcile every month with finance and the distributor, and review before renewal. A term nobody reviews becomes a cost nobody chose.
Know what the spending buys
Ask what a symposium cost and you'll hear the venue invoice. Return on promotion counts the full cost of calls, meetings and samples, and measures the result in prescribing and patients, never attendance. Every activity stays inside the code of practice.
Cost per call is the full cost of a rep for a year divided by real calls in the chosen segments. It shows how many calls go outside the priority segments, and which customers a remote call or a scientific meeting could serve. Share it with the whole team and use it to plan coverage, never to judge 1 rep.
For the A&P budget, budgeting without guessing means zero-based thinking: nothing is funded by default. Start from the brand objective, build each activity from zero, then rank, fund and stop. Review quarterly. Every line in the budget should be able to say why it's there.
Read the numbers honestly
Some of the best-looking months are the month that was bought. The pattern: sell-in up, sell-out flat, distributor stock up. That stock is next month's sales, already spent. When you see it, make the conversation about learning. A month you bought is a month you will pay back.
IQVIA data used properly shows what moved, and the field explains why. IQVIA describes its audits as built from a panel of sources and projected to a national estimate, so read the trend over the point, check what each channel covers, and never use it to rank reps.
Market share versus growth needs 4 readings: market growth, your growth on sell-out, your share over several months, and your growth against the market's. Agree with headquarters before the year starts which counts, so a team that won ground in a shrinking market isn't judged on the sales line alone.
Carry fewer promises
The cost of complexity builds one small yes at a time: a pack size, a strength, a special term. Once a year, list everything you carry and promise, and ask what each adds for patients and customers. Retire the rest properly, with customers told early, the authority informed and patient supply protected.
The same honesty applies to investing in a losing brand. Kahneman writes about the sunk-cost fallacy: money already spent feels like a reason to keep spending. Ask what the next budget can still earn, and have someone outside the brand team test the case. Money already spent should not vote on money not yet spent.
Your checklist for this week
- Review sales, profit and cash with your finance manager, then share the picture with your managers
- Read net sales before gross sales in this month's P&L
- Put sell-in, sell-out and distributor inventory side by side for every key brand
- Write down the assumptions behind your forecast, one sentence each
- Set a walk-away net price for your next key tender
- Check that every rebate pays on sell-out and has a cap and an end date
- Pick 1 A&P activity and ask why it's there
That's Step 3. Next week Step 4 begins: distributors and market access, starting with how to choose a distributor.